Careers  |  Sign In  |  Register  |   Twitter

Latest in Dermatology

Reuters Health • The Doctor's Channel Daily Newscast

Anti-TNF antibody treatment may raise risk of shingles

NEW YORK (Reuters Health) – In patients with rheumatoid arthritis, anti-tumor necrosis factor (TNF) treatment with adalimumab and infliximab is associated with a small increased risk of herpes zoster, researchers report in the Journal of the American Medical Association for February 18. The anti-TNF...

Reuters Health • The Doctor's Channel Daily Newscast

Rituximab safe for systemic sclerosis, but efficacy open to question

NEW YORK (Reuters Health) – In patients with diffuse cutaneous systemic sclerosis (dcSSc), treatment with rituximab depletes B cells in the peripheral circulation and in skin, with few adverse events. On the other hand, results of a 6-month pilot study failed to show any clear beneficial effect on...

Reuters Health • The Doctor's Channel Daily Newscast

Mortality high in patients with systemic scleroderma and pulmonary hypertension

NEW YORK (Reuters Health) – The prognosis for patients with systemic sclerosis complicated by pulmonary hypertension is “grim,” particularly among African Americans and those with interstitial lung disease, physicians at Johns Hopkins University, Baltimore, report in the February issue of...